Indeed, TIM-3 expression is regarded as a marker for terminally differentiated effector and exhausted cells [12], thereby suggesting that CD4+ and CD8+ T cells and NK cells may be terminally exhausted in glioblastoma patients. Here, CD8A is linked to glioblastoma.